AOD-9604
MetabolicResearch only — not approvedAOD
A modified hGH fragment logged as a fasted morning subcutaneous research compound.
- Typical form
- Lyophilized vial
- Typical route
- Subcutaneous
- Display unit
- mcg
- Typical vial
- 5 mg
- Half-life (approx.)
- 0.5 h
- Default in-use window
- 28 days
Educational · commonly logged
Typical protocol
A snapshot of how this compound is logged — not a prescription. You set every number.
- Common range
- 250–500 mcg
- Starting log
- 300 mcg
- Cadence
- 5 on / 2 off
- Timing
- Morning, fasted
- Duration
- 8–12 weeks
mcg-scale daily or 5/2. This is not a GLP-1 and not somatropin.
Reconstitution note
mcg-scale daily. 5/2 schedules are common in community logs.
Storage
Fridge after mix.
Cautions
Not a GLP-1 and not somatropin.
Evidence posture
Development as an obesity drug did not yield an approval.